Literature DB >> 17525396

Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study.

Toshiharu Ninomiya1, Michiaki Kubo, Yasufumi Doi, Koji Yonemoto, Yumihiro Tanizaki, Mahbubur Rahman, Hisatomi Arima, Kazuhiko Tsuryuya, Mitsuo Iida, Yutaka Kiyohara.   

Abstract

BACKGROUND AND
PURPOSE: The metabolic syndrome (MetS) is associated with an increased risk of cardiovascular disease (CVD) events in general populations. However, well-designed prospective studies in Asian populations are very limited.
METHODS: We prospectively evaluated a total of 2452 community-dwelling Japanese individuals aged 40 years or older from 1988 to 2002 and examined the effects of MetS defined by the modified National Cholesterol Education Program Adult Treatment Panel III criteria on incident CVD.
RESULTS: The prevalence of the MetS was 21% in men and 30% in women at baseline. During the follow up, 307 CVD events occurred. Compared with those without MetS, the age-adjusted incidence of CVD (per 1000 person-years) was significantly higher in subjects with the MetS in both men (21.8 versus 11.6, P<0.01) and women (12.9 versus 6.5, P<0.01). The risk of CVD events was significantly higher even after adjusting for the following confounding factors: age, proteinuria, electrocardiographic abnormalities, serum total cholesterol, smoking habits, alcohol intake, and regular exercise (hazard ratio, 1.86; 95% CI, 1.32 to 2.62 in men and hazard ratio, 1.70; 95% CI, 1.22 to 2.36 in women). The risk of incident CVD was found to increase with the number of components of MetS and became significantly predictive when the number of components reached 3. Similar associations were also observed when CVD was divided into coronary heart disease and stroke.
CONCLUSIONS: Our findings suggest that MetS is a significant risk factor for the development of CVD in the Japanese middle-aged population.

Entities:  

Mesh:

Year:  2007        PMID: 17525396     DOI: 10.1161/STROKEAHA.106.479642

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  47 in total

1.  Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men.

Authors:  K Nakamura; M Sakurai; K Miura; Y Morikawa; M Ishizaki; K Yoshita; T Kido; Y Naruse; H Nakagawa
Journal:  Diabetologia       Date:  2010-05-26       Impact factor: 10.122

2.  Effect of metabolic syndrome components and their clustering on carotid atherosclerosis in a sample of the general Japanese population.

Authors:  Chiaki Hirata; Nobuyuki Miyai; Ayaka Idoue; Miyoko Utsumi; Sonomi Hattori; Akihiko Iwahara; Yuji Uematsu; Mitsuru Shiba; Mikio Arita
Journal:  Hypertens Res       Date:  2016-01-21       Impact factor: 3.872

3.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

4.  Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan.

Authors:  Kazufumi Nagahama; Taku Inoue; Kentaro Kohagura; Kozen Kinjo; Yusuke Ohya
Journal:  Hypertens Res       Date:  2014-11-06       Impact factor: 3.872

5.  The effects of atypical antipsychotic usage duration on serum adiponectin levels and other metabolic parameters.

Authors:  Elif Oral; Mustafa Gulec; Nezahat Kurt; Sumeyra Yilmaz; Nazan Aydin; Ismet Kirpinar
Journal:  Eurasian J Med       Date:  2011-04

6.  Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome.

Authors:  T Suzuki; Z Zeng; B Zhao; Z Wei; M Tanabe; T Shimbo; H Kajio; N Kato; M Naruse
Journal:  J Endocrinol Invest       Date:  2016-08-29       Impact factor: 4.256

7.  Chromosome 9p21 rs10757278 polymorphism is associated with the risk of metabolic syndrome.

Authors:  Burcu Bayoglu; Huseyin Altug Cakmak; Husniye Yuksel; Gunay Can; Bilgehan Karadag; Turgut Ulutin; Vural Ali Vural; Mujgan Cengiz
Journal:  Mol Cell Biochem       Date:  2013-03-28       Impact factor: 3.396

8.  Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama Study.

Authors:  T Ohkuma; H Fujii; M Iwase; Y Kikuchi; S Ogata; Y Idewaki; H Ide; Y Doi; Y Hirakawa; N Mukai; T Ninomiya; K Uchida; U Nakamura; S Sasaki; Y Kiyohara; T Kitazono
Journal:  Diabetologia       Date:  2012-10-13       Impact factor: 10.122

9.  Etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:  Kojiro Michitaka; Shuhei Nishiguchi; Yutaka Aoyagi; Yoichi Hiasa; Yoshio Tokumoto; Morikazu Onji
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

10.  Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study.

Authors:  Naoko Mukai; Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Masanori Iwase; Mitsuo Iida; Yutaka Kiyohara
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.